| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| APLS | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | May 08, 2024 | Sale | $42.35 | 78,907 | 3,341,848 | 1,138,555 | May 09, 2024, 05:15 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | May 08, 2024 | Option Exercise | $4.31 | 78,907 | 340,089 | 1,194,890 | May 09, 2024, 05:15 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | Apr 08, 2024 | Option Exercise | $3.76 | 69,107 | 259,842 | 1,185,090 | Apr 09, 2024, 04:25 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | Apr 08, 2024 | Sale | $54.17 | 69,107 | 3,743,605 | 1,120,711 | Apr 09, 2024, 04:25 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | Mar 08, 2024 | Option Exercise | $3.67 | 69,107 | 253,623 | 1,185,090 | Mar 11, 2024, 04:08 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | Mar 08, 2024 | Sale | $62.19 | 69,107 | 4,297,549 | 1,142,340 | Mar 11, 2024, 04:08 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | Feb 12, 2024 | Sale | $67.77 | 1,148 | 77,796 | 1,115,983 | Feb 13, 2024, 04:43 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | Jan 29, 2024 | Sale | $64.14 | 874 | 56,057 | 1,117,131 | Jan 31, 2024, 04:21 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | Jan 22, 2024 | Sale | $65.00 | 3,913 | 254,329 | 1,118,005 | Jan 23, 2024, 06:03 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | Jan 16, 2024 | Sale | $66.81 | 1,632 | 109,032 | 1,121,918 | Jan 17, 2024, 04:47 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | Nov 14, 2023 | Option Exercise | $3.76 | 45,000 | 169,200 | 1,116,807 | Nov 15, 2023, 04:10 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | Nov 08, 2023 | Sale | $47.27 | 12,000 | 567,240 | 1,071,807 | Nov 09, 2023, 04:18 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | Nov 08, 2023 | Option Exercise | $2.67 | 17,494 | 46,709 | 1,083,807 | Nov 09, 2023, 04:18 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | Oct 09, 2023 | Option Exercise | $2.67 | 18,500 | 49,395 | 1,078,313 | Oct 10, 2023, 04:26 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | Oct 09, 2023 | Sale | $40.38 | 12,000 | 484,560 | 1,066,313 | Oct 10, 2023, 04:26 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | Sep 08, 2023 | Option Exercise | $2.67 | 18,500 | 49,395 | 1,071,813 | Sep 11, 2023, 04:58 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | Sep 08, 2023 | Sale | $42.87 | 12,000 | 514,440 | 1,059,813 | Sep 11, 2023, 04:58 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | Aug 08, 2023 | Option Exercise | $2.67 | 18,500 | 49,395 | 1,065,313 | Aug 09, 2023, 04:08 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | Aug 08, 2023 | Sale | $23.66 | 12,000 | 283,920 | 1,053,313 | Aug 09, 2023, 04:08 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | Jul 10, 2023 | Option Exercise | $2.67 | 18,500 | 49,395 | 1,058,813 | Jul 11, 2023, 05:37 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | Jul 10, 2023 | Sale | $84.55 | 12,000 | 1,014,600 | 1,046,813 | Jul 11, 2023, 05:37 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | Jun 08, 2023 | Sale | $91.35 | 12,000 | 1,096,200 | 1,040,313 | Jun 09, 2023, 04:40 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | Jun 08, 2023 | Option Exercise | $2.67 | 18,500 | 49,395 | 1,052,313 | Jun 09, 2023, 04:40 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | May 08, 2023 | Option Exercise | $2.67 | 18,500 | 49,395 | 1,045,813 | May 09, 2023, 05:02 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | May 08, 2023 | Sale | $92.39 | 12,000 | 1,108,680 | 1,033,813 | May 09, 2023, 05:02 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | Apr 10, 2023 | Option Exercise | $2.67 | 18,500 | 49,395 | 1,039,313 | Apr 11, 2023, 04:20 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | Apr 10, 2023 | Sale | $78.21 | 12,000 | 938,520 | 1,027,313 | Apr 11, 2023, 04:20 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | Mar 08, 2023 | Option Exercise | $2.67 | 18,500 | 49,395 | 1,032,813 | Mar 10, 2023, 05:18 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | Mar 08, 2023 | Sale | $63.79 | 12,000 | 765,480 | 1,020,813 | Mar 10, 2023, 05:18 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | Feb 21, 2023 | Option Exercise | $58.50 | 1,195 | 69,908 | 1,014,313 | Feb 22, 2023, 06:44 AM | |
| APLS | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | Feb 10, 2023 | Option Exercise | $51.21 | 1,134 | 58,072 | 1,005,622 | Feb 14, 2023, 04:28 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | Feb 08, 2023 | Option Exercise | $2.67 | 18,500 | 49,395 | 1,018,756 | Feb 10, 2023, 05:00 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | Feb 08, 2023 | Sale | $54.45 | 12,000 | 653,400 | 1,006,756 | Feb 10, 2023, 05:00 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | Jan 27, 2023 | Option Exercise | $52.77 | 832 | 43,905 | 1,000,256 | Jan 30, 2023, 04:47 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | Jan 20, 2023 | Option Exercise | $52.05 | 2,326 | 121,068 | 1,001,088 | Jan 24, 2023, 05:14 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | Jan 09, 2023 | Option Exercise | $2.67 | 18,500 | 49,395 | 995,780 | Jan 10, 2023, 08:07 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | Jan 09, 2023 | Sale | $46.08 | 12,000 | 552,960 | 983,780 | Jan 10, 2023, 08:07 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | Dec 29, 2022 | Option Exercise | $3.67 | 7,000 | 25,690 | 977,280 | Dec 30, 2022, 05:00 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | Dec 08, 2022 | Option Exercise | $2.67 | 18,500 | 49,395 | 982,280 | Dec 12, 2022, 04:28 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | Dec 08, 2022 | Sale | $47.50 | 12,000 | 570,000 | 970,280 | Dec 12, 2022, 04:28 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | Nov 08, 2022 | Option Exercise | $2.67 | 18,500 | 49,395 | 975,780 | Nov 10, 2022, 08:30 AM | |
| APLS | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | Nov 08, 2022 | Sale | $46.47 | 12,000 | 557,640 | 963,780 | Nov 10, 2022, 08:30 AM | |
| APLS | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | Oct 10, 2022 | Sale | $57.50 | 12,000 | 690,000 | 957,280 | Oct 11, 2022, 04:58 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | Oct 10, 2022 | Option Exercise | $2.67 | 18,500 | 49,395 | 969,280 | Oct 11, 2022, 04:58 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | Sep 08, 2022 | Option Exercise | $2.67 | 18,500 | 49,395 | 962,780 | Sep 12, 2022, 04:52 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | Sep 08, 2022 | Sale | $63.98 | 12,000 | 767,760 | 950,780 | Sep 12, 2022, 04:52 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | Aug 08, 2022 | Option Exercise | $2.67 | 18,500 | 49,395 | 956,280 | Aug 09, 2022, 05:18 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | Aug 08, 2022 | Sale | $62.50 | 12,000 | 750,000 | 944,280 | Aug 09, 2022, 05:18 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | Jul 08, 2022 | Sale | $47.95 | 12,000 | 575,400 | 937,780 | Jul 12, 2022, 04:04 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | Jul 08, 2022 | Option Exercise | $2.67 | 18,500 | 49,395 | 949,780 | Jul 12, 2022, 04:04 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | Jun 17, 2022 | Option Exercise | $2.67 | 33,005 | 88,123 | 931,280 | Jun 22, 2022, 04:32 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | Jun 08, 2022 | Option Exercise | $2.67 | 18,500 | 49,395 | 903,775 | Jun 09, 2022, 05:23 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | Jun 08, 2022 | Sale | $44.09 | 12,000 | 529,080 | 891,775 | Jun 09, 2022, 05:23 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | Apr 29, 2022 | Sale | $44.43 | 4,000 | 177,720 | 891,775 | May 02, 2022, 08:05 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | Apr 29, 2022 | Option Exercise | $2.67 | 4,000 | 10,680 | 895,775 | May 02, 2022, 08:05 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | Jan 28, 2022 | Option Exercise | $38.59 | 931 | 35,927 | 894,707 | Feb 01, 2022, 06:00 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | Jun 24, 2021 | Option Exercise | $2.67 | 6,250 | 16,688 | 875,837 | Jun 25, 2021, 09:48 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | Jun 24, 2021 | Sale | $65.61 | 6,250 | 410,063 | 869,587 | Jun 25, 2021, 09:48 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | Apr 28, 2021 | Option Exercise | $2.67 | 4,500 | 12,015 | 869,587 | Apr 29, 2021, 05:11 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | Apr 23, 2021 | Option Exercise | $2.67 | 6,250 | 16,688 | 871,337 | Apr 26, 2021, 06:02 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | Apr 23, 2021 | Sale | $46.13 | 6,250 | 288,313 | 865,087 | Apr 26, 2021, 06:02 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | Mar 10, 2021 | Option Exercise | $2.67 | 6,250 | 16,688 | 871,337 | Mar 11, 2021, 04:08 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | Mar 10, 2021 | Sale | $50.74 | 6,250 | 317,125 | 865,087 | Mar 11, 2021, 04:08 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Scientific Officer | Feb 10, 2021 | Option Exercise | $47.72 | 688 | 32,831 | 865,087 | Feb 11, 2021, 04:12 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Operating Officer | Feb 13, 2020 | Sale | $40.98 | 55,398 | 2,270,155 | 1,008,681 | Feb 14, 2020, 04:49 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Operating Officer | Feb 12, 2020 | Option Exercise | $2.14 | 117,206 | 250,821 | 998,949 | Feb 14, 2020, 04:49 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Operating Officer | Feb 12, 2020 | Sale | $42.80 | 52,075 | 2,228,966 | 946,874 | Feb 14, 2020, 04:49 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Operating Officer | Feb 13, 2020 | Option Exercise | $2.14 | 117,205 | 250,819 | 1,064,079 | Feb 14, 2020, 04:49 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Operating Officer | Sep 25, 2019 | Sale | $25.26 | 21,541 | 544,059 | 882,753 | Sep 26, 2019, 04:06 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Operating Officer | Sep 24, 2019 | Sale | $24.58 | 21,602 | 531,081 | 904,579 | Sep 25, 2019, 04:26 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Deschatelets Pascal | Chief Operating Officer | Sep 23, 2019 | Sale | $25.07 | 20,858 | 522,915 | 924,986 | Sep 25, 2019, 04:26 PM |
Menu